U.S. Markets open in 9 hrs 25 mins

Oncternal Therapeutics, Inc. (ONCT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
5.80+0.50 (+9.43%)
At close: 4:00PM EDT
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2021)Next Qtr. (Jun 2021)Current Year (2021)Next Year (2022)
No. of Analysts4443
Avg. Estimate-0.1-0.11-0.49-0.75
Low Estimate-0.11-0.12-0.55-1.05
High Estimate-0.08-0.1-0.41-0.57
Year Ago EPSN/AN/A-0.85-0.49
Revenue EstimateCurrent Qtr. (Mar 2021)Next Qtr. (Jun 2021)Current Year (2021)Next Year (2022)
No. of Analysts4433
Avg. Estimate1.11M1.24M6.37M1.68M
Low Estimate550k550k3.24MN/A
High Estimate1.75M2.25M9.75M4M
Year Ago Sales578k623k3.38M6.37M
Sales Growth (year/est)92.00%99.00%88.70%-73.60%
Earnings HistoryInvalid DateInvalid Date9/30/202012/31/2020
EPS Est.N/AN/A-0.3-0.18
EPS ActualN/AN/A-0.22-0.09
DifferenceN/AN/A0.080.09
Surprise %N/AN/A26.70%50.00%
EPS TrendCurrent Qtr. (Mar 2021)Next Qtr. (Jun 2021)Current Year (2021)Next Year (2022)
Current Estimate-0.1-0.11-0.49-0.75
7 Days Ago-0.1-0.11-0.49-0.75
30 Days Ago-0.1-0.12-0.52-0.81
60 Days Ago-0.12-0.14-0.59-1
90 Days Ago-0.11-0.12-0.482.24
EPS RevisionsCurrent Qtr. (Mar 2021)Next Qtr. (Jun 2021)Current Year (2021)Next Year (2022)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesONCTIndustrySector(s)S&P 500
Current Qtr.N/AN/AN/AN/A
Next Qtr.N/AN/AN/AN/A
Current Year42.40%N/AN/AN/A
Next Year-53.10%N/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A